A woman underwent surgery for myomectomy, but surgeon could not detect a fibroid and did not open uterus.
A New York woman underwent surgery in 2004. The operation was intended to be a myomectomy, but the surgeon could not detect a fibroid and determined that the patient's bleeding and pain were due to adenomyosis. He wanted to preserve the patient's fertility and did not open the uterus. The operation was ended and an MRI scan was ordered, which found that the patient did have a large, degenerating uterine fibroid. The patient decided that she did not want to undergo removal of the fibroid. In 2007, she did undergoa hysterectomy for the fibroid, at the age of 31.
The woman then sued the gynecologist and alleged negligence in failing to diagnose and treat the fibroid. She claimed that an MRI scan should have been performed before the first surgery, which would have conclusively revealed the fibroid and would have allowed for proper performance of the original surgery. She also claimed that an intraoperative biopsy would have revealed the presence of the fibroid.
The physician claimed that fibroids do not necessarily require surgical intervention and that adenomyosis was a reasonable diagnosis. He also claimed that the patient's outcome would not have been improved by conclusive presurgical detection of the fibroid. A defense verdict was returned.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More